Archive for the ‘News’ Category

‘Bad Luck 2.0’ – the transformation to success

Author: Sara M. Nolte, 09/12/17

Over two years ago, an article published in Science took the Internet and media by storm. The paper, “Variation in cancer risk among tissues can be explained by the number of stem cell divisions,” better known as “The ‘Bad Luck’ Cancer Study,” used mathematical modeling to demonstrate that most cancers were a result of chance…Read more

Right Turn: ‘Right to try’ state of affairs in U.S.

Author: Stacey Johnson, 08/25/17

On Tuesday, August 29, Signals is hosting a blog carnival on the topic Right to Try. Before you read the perspectives of the contributing bloggers, here’s what President Trump thinks about the legislation and the Goldwater Institute’s reaction. It’s the Institute that took on this cause in the first place. Earlier this month, the U.S….Read more

Right Turn: Clinical trials – one solution to unapproved stem cell treatments

Author: Stacey Johnson, 07/14/17

I’ve been thinking about unapproved stem cell treatments a lot recently. First, I read this article that hailed the arrival of stem cell treatments in a small community in western Canada. There were many statements in the article that concerned me, but I only addressed a few major ones in my letter to the editor….Read more

Right Turn: Eventual relief for those suffering from Crohn’s?

Author: Stacey Johnson, 05/26/17

Recently, a friend posted on Facebook the news about her teenage son who, a year ago, had been suffering from an undiagnosed condition. Her son’s doctor didn’t treat the symptoms very seriously until the mother insisted something was wrong and implored him to identify the cause. Finally, her son was diagnosed with Crohn’s disease. Along…Read more

Right Turn: The robots aren’t coming, they’re here

Author: Stacey Johnson, 03/31/17

via GIPHY Artificial Intelligence (AI) already permeates our culture and that’s only going to increase with time and advances to the technology. Some think this is good news, progress and inevitable while others, like Stephen Hawking for example, fear where AI could take us. AI is on my mind this week with the announcement that…Read more

Right Turn: New stem cell product for ALS seeking approval in Canada

Author: Stacey Johnson, 02/24/17

This week, BrainStorm Cell Therapeutics issued a news release announcing its intent to seek early regulatory approval to distribute its Amyotrophic Lateral Sclerosis (ALS) product to patients in Canada. This news was eagerly received by patient groups in Canada and internationally. ALS, also known as Lou Gehrig’s Disease, is a progressive neuromuscular disease in which…Read more

Right Turn: Good news for Canadian “butterfly boy”

Author: Stacey Johnson, 01/27/17

Epidermolysis bullosa (EB) is a rare, and exceedingly painful, skin condition that I’ve written about here and here. Children with EB are sometimes referred to as “butterfly children” because their skin is said to be as fragile as a butterfly’s wings. The severity of the condition ranges from mild to fatal. Jonathan Pitre is a…Read more

Making a case for research investment in Canada: Can we drive reverse brain drain now?

Author: Camila Londono, 01/11/17

Brain drain was a real problem for Canada in the late ‘90s. A study by Statistics Canada found that twice as many post-secondary professors and teachers went to the United States than came to Canada in that period. This untenable situation—in which education and infrastructure investments in people were lost through decreased funding, higher taxes…Read more

Crazy for CRISPR!

Author: Sara M. Nolte, 12/05/16

On November 15th, my social media pages exploded with posts and comments regarding the latest news about how the gene-editing ‘CRISPR-Cas9’ technology had been used in the first human patient. The article, published by Nature, was entitled “CRISPR gene-editing tested in a person for the first time.” It described how a group of Chinese scientists…Read more

Right Turn: What do the results of the U.S. election mean for science?

Author: Stacey Johnson, 11/09/16

This isn’t the blog that I planned to write this week, but I’m so preoccupied with the outcome of the U.S. election, I’m finding it hard to focus on anything else right now. So, let’s look at the implications of a Trump presidency on science. An article in Nature quotes Michael Lubell, director of public…Read more